chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Pain in arm, hurts to move, worse at night; hurts to move; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than 2 months after receiving Shingles vaccine, the patient experienced pain in arm and mobility decreased. On an unknown date, the outcome of the pain in arm and mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and mobility decreased to be related to Shingles vaccine.  Additional details were provided as follows: The case was self-reported by the patient. The age at vaccination was not reported. The patient received 1st dose of Shingles shot almost 5 weeks ago from the date of reporting. After receiving Shingles vaccine, the patient experienced pain in arm and still having it till the time of reporting. The patient reported that, it hurt to move it certain directions and was worse usually at night. The patient had taken anti-inflammatory. The patient was sending for MRI a day after date of reporting, on 08th March 2022, that would cost 450.
Sex: U
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Gave a 3rd dose; This case was reported by a physician via sales rep and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (Received first and second dose on an unknown date).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were reported as follows: The age at vaccination was not reported. The patient received 3rd dose of Shingrix, which led to Extra dose administered. The reporter consented to follow up.
Sex: F
Vaccine: VARZOS
Symptoms: Back pain
Clinical narrative: back hurts; This case was reported by a consumer via interactive digital media and described the occurrence of back pain in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced back pain. On an unknown date, the outcome of the back pain was unknown.   It was unknown if the reporter considered the back pain to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was unknown. The reporter wanted to know if Shingrix caused back pain. The patient was referred to her health care provider as her primary resource for patient care. The patient was provided with the link for the package insert. The patient stated that her back hurts and wanted to know if it could be the vaccine. The patient stated that she could not see back pain listed specifically in the prescribing information but she did see myalgia which was muscle pain. The patient stated that she did not want to give her private information over text. Patient was wondering what myalgia was, so the pain could be in different places on the body. The patient further stated she was going to call her health care provider. The patient stated that the literature just said, myalgia but it did not say where on the body specifically. The patient was informed that her question was important which required medical advice, because patient care was individualized, a healthcare provider should always be consulted to evaluate patients health and provide guidance to patient based on patients medical history.  The follow-up would not be possible as no contact details were available.
Sex: U
Vaccine: HEPAB
Symptoms: Expired product administered
Clinical narrative: Administered dose past the expiration date; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAB (Twinrix) (batch number unknown, expiry date 28th February 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at vaccination was not reported. The patient was administered with Twinrix past the expiration date, the vaccine was expired on 28th February 2022, which led to expired vaccine used. The reporter asked what he/she need to do for this patient. The health care professional (HCP) disconnected after it was asked for credentials and therefore, no additional information available. The reporter did not consent to follow-up.
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Scab, Tenderness
Clinical narrative: Broke out in shingles, tender; Shingles blistered; Shingles were tender; Shingles blistered and now are starting to crust over; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd March 2022, the patient received the 1st dose of Shingrix (intramuscular). On 4th March 2022, 1 days after receiving Shingrix, the patient experienced shingles, blister, tenderness and crust. On an unknown date, the outcome of the shingles, blister, tenderness and crust were not recovered/not resolved.   It was unknown if the reporter considered the shingles, blister, tenderness and crust to be related to Shingrix.  Additional details were reported as follows: The reporter is the patient's wife. The reporter stated that, her husband received his first Shingrix vaccine on 3rd March 2022, in the Left arm and broke out in a case of shingles the next day of vaccination. The reporter stated that, the shingles were on the right side of his belly that were now blistered and were started to crust over. The reporter stated that her husband told her that the shingles were tender but not painful. The reporter stated that their daughter was a Physician Assistant who looked to verify shingles. The reporter stated that, she also took pictures from the day of occurring (the outbreak) to the day of reporting, which she would be glad to share with GlaxoSmithKline. The reporter denied consent to follow-up and does not gave permission to contact HCP (health care professional).
Age: 87.0
Sex: F
Vaccine: HEP
Symptoms: Accidental underdose, Product administered to patient of inappropriate age
Clinical narrative: adult administered a pediatric dose; adult administered a pediatric dose; This case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 87-year-old female patient who received HBV (Engerix B 10 mcg) (batch number 25N39, expiry date 16th March 2024) for prophylaxis.   Previously administered products included Engerix B with an associated reaction of therapy non-responder (previously completed the series on an unknown date, but titer testing was negative, refer link case US2022AMR044159) and Engerix B (1st dose received on an unknown date of readministered series).   On 7th February 2022, the patient received the 2nd dose of Engerix B 10 mcg. On 7th February 2022, unknown after receiving Engerix B 10 mcg, the patient experienced accidental underdose and adult use of a child product. On an unknown date, the outcome of the accidental underdose and adult use of a child product were unknown.   Additional details were reported as follows: The medical assistant reported that, an adult patient was inadvertently administered a pediatric dose of Engerix-B, which led to accidental underdose and adult use of a child product.  At the time of reporting, this dose had not been repeated. This patient previously completed the series, but titer testing was negative, so the series was being re-administered, refer linked case US2022AMR044159.   The reporter consented to follow up. This case had been linked with case US2022018153, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022018153:Same reporter US-GLAXOSMITHKLINE-US2022AMR044159:same reporter
Age: 71.0
Sex: M
Vaccine: COVID19, VARZOS
Symptoms: Asthenia, Fatigue
Clinical narrative: Tiredness; Lack of energy; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included covid-19 vaccine for prophylaxis.   In December 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the patient received the a dose of covid-19 vaccine. In December 2021, immediately after receiving Shingrix, the patient experienced tiredness and loss of energy. On an unknown date, the outcome of the tiredness and loss of energy were not recovered/not resolved.   It was unknown if the reporter considered the tiredness and loss of energy to be related to Shingrix.  Additional details were provided as follows: The reporter was patient's wife. The reporter reported that patient experienced tiredness and lack of energy shortly after the Shingrix vaccine. The patient also had the Covid vaccine around the same time so reporter was not sure if patients symptoms were from the Shingrix or Covid vaccine. No other information was provided. Consent for follow up was denied.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was left out in room temperature post-punctured over 12 hours and "one" patient received booster; Vaccine was left out in room temperature post-punctured over 12 hours and one patient received booster; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was left out in room temperature post-punctured over 12 hours and one patient received booster) and PRODUCT STORAGE ERROR (Vaccine was left out in room temperature post-punctured over 12 hours and "one" patient received booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2022 at 2:56 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2022 at 2:56 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was left out in room temperature post-punctured over 12 hours and one patient received booster). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was left out in room temperature post-punctured over 12 hours and "one" patient received booster). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was left out in room temperature post-punctured over 12 hours and one patient received booster) and PRODUCT STORAGE ERROR (Vaccine was left out in room temperature post-punctured over 12 hours and "one" patient received booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported.  Treatment details were not given. Vial was first punctured on 07-Mar-2022 around 9:00 AM . It did not undergo any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 09-Mar-2022: Follow up received contains significant information- As involved patient number updated from  two to one.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Candida infection, Rhinorrhoea, Skin lesion
Clinical narrative: thrush; lesions; sniffles for 2 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (sniffles for 2 days after first dose), CANDIDA INFECTION (thrush) and SKIN LESION (lesions) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (sniffles for 2 days after first dose), CANDIDA INFECTION (thrush) and SKIN LESION (lesions). The patient was treated with EUCALYPTUS GLOBULUS OIL, MENTHOL (ROBITUSSIN COUGH DROPS) for Thrush, at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (sniffles for 2 days after first dose) had resolved and CANDIDA INFECTION (thrush) and SKIN LESION (lesions) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitant products were not provided. This case was linked to MOD-2022-506705 (Patient Link).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: Patient was tired for two days; Had chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Had chills) and FATIGUE (Patient was tired for two days) in a 73-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Feb-2022, the patient experienced CHILLS (Had chills). On 03-Feb-2022, the patient experienced FATIGUE (Patient was tired for two days). On 02-Feb-2022, CHILLS (Had chills) had resolved. In February 2022, FATIGUE (Patient was tired for two days) had resolved.        mRNA-1273 (Spikevax) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.  No treatment details were reported.   This case was linked to MOD-2022-507465 (Patient Link).
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling in left side of face and in left fingers. Paresthesia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Jul2021 13:00 (Batch/Lot number: unknown) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "cavernoma" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes; "a few other antibiotics allergy" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: PARAESTHESIA (non-serious) with onset 26Jul2021, outcome "not recovered", described as "tingling in left side of face and in left fingers. Paresthesia". It was unknown if therapeutic measures were taken as a result of paraesthesia.  Additional information: The patient not tested for Covid post vaccination. No any other vaccine in four weeks. Unspecified medications took in two weeks. Facility type Vaccine: Pharmacy or Drug Store  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise
Clinical narrative: Feeling sick; Headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Batch/Lot number: unknown) at the age of 55 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 01Apr2021, outcome "unknown", described as "Feeling sick"; HEADACHE (non-serious) with onset 01Apr2021, outcome "unknown", described as "Headache".  Additional information: The patient received first shot in the morning and in the afternoon, the patient was feeling sick and had a headache.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a contactable Pharmacist (patient himself). A male patient of un-specified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution of injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. Patients medical history and concomitant medications were not reported. After vaccination, patient experienced sore arm on an unspecified date. The outcome of event was unknown.   Caller was looking for information on any neurological side effects that can be caused by the Pfizer COVID-19 vaccine. He stated his brother sent him a 29 minute long video of this doctor claiming that you are going to be a crippled after receiving the vaccine, caller sated in theory that could hap-pen but it would be so rare, this guy was just trying to scare everyone into not getting the vaccine and that was the last thing we need was for people not to receive the vaccine.  Information about the Lot/batch number has been requested.  Follow-up (13Sep2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: she already took second vaccine two weeks ago approx. and just had a little of general malaise; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Jul2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 01), administration date: 07Jul2021, for Covid-19 Immunization. The following information was reported: MALAISE (non-serious) with onset Jul2021, outcome "unknown", described as "she already took second vaccine two weeks ago approx. and just had a little of general malaise".  Additional information: It was reported that Caller got the 1st dose of the Pfizer COVID-19 vaccine in on 07Jul2021 where her daughter lives and does not have a schedule for her 2nd dose yet. She was told from people in that she was not allowed to get the 2nd dose and she was confused. Also indicates she already took second vaccine two weeks ago approx. and just had a little of general malaise. Also indicates she already took second vaccine two weeks ago approx. and just had a little of general malaise. Follow-up attempts completed. No further information is expected.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Flushing, Hyperhidrosis, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Weakness-Mild, Additional Details: pt partner notified me after shot pt fainted.  called 911. applied cool compress and offered sip water to wake pt. 911 arrived recommend pt take to ed.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Injection site erythema, Injection site swelling
Clinical narrative: Large red swollen injection site. Fautigue, chills and joint pains, swollen lymph node in armpit
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Large red swollen injection site. Fautigue, chills and joint pains, swollen lymph node in armpit
Age: 31.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Injected limb mobility decreased, Pain, Peripheral swelling, Pyrexia
Clinical narrative: Swelling in left arm. Inability to move arm without pain. 10/10 pain. Fever last night m.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Lymphadenopathy, Vaccine positive rechallenge
Clinical narrative: Site: Swelling at Injection Site-Medium, Systemic: LYMPH NODE SWELLING IN THE UNDERARM AND NECK-Medium, Systemic: Lymph Node Swelling-Medium, Additional Details: PATIENT HAD ALREADY EXPERIENCED THE SAME SIDE EFFECTS ON HER 2ND DOSE OF PFIZER COVID VACCINE. IT HAPPENED AGAIN ON THE 3RD DOSE. RPH ADVISED HER TO TAKE IBUPROFEN FOR THE LYMPH NODE SWELLIGN AND CLARITIN AS WELL.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dehydration, Malaise, Pain
Clinical narrative: Fever, severe body aches, severe chills, vomiting, dehydration, weakness. These symptoms lasted for a full day. Then 2-3 days of recovering from being so sick.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Fever, severe body aches, severe chills, vomiting, dehydration, weakness. These symptoms lasted for a full day. Then 2-3 days of recovering from being so sick.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia
Clinical narrative: 3 days after receiving  a booster dose of vaccine I experienced significant voice changes (hoarseness, weak/fluctuating voice)
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 3/16/21, 4/6/21, 10/6/21. Positive on 3/10/22
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glioblastoma, Intracranial mass, Magnetic resonance imaging head abnormal, Necrosis
Clinical narrative: Glioblastoma, IDH-wildtypeby IHC. Left temporal (with extension to left basal ganglia and insula) glioblastoma, IDH, wildtype by IHC
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Inflammation, Injection site bruising, Orthopaedic examination normal, Swelling face
Clinical narrative: Face swelling, eye swelling, right arm inflammation from elbow to top of shoulder to  the mid back.  bruise at injection site for 7 months.   The face/ eye swelling lasted for 3 months.  The eye swelling was severe enough that I could not wear contact lenses. I still have face swelling in my cheek on the left side of my face.  For my arm, I saw  an orthopedic doctor who ruled out any joint/tears/ bone issues and diagnosed  inflammation and recommended exercise and massage to reduce inflammation.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: Face swelling, eye swelling, right arm inflammation from elbow to top of shoulder to  the mid back.  bruise at injection site for 7 months.   The face/ eye swelling lasted for 3 months.  The eye swelling was severe enough that I could not wear contact lenses. I still have face swelling in my cheek on the left side of my face.  For my arm, I saw  an orthopedic doctor who ruled out any joint/tears/ bone issues and diagnosed  inflammation and recommended exercise and massage to reduce inflammation.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Impaired work ability, Pain, Pyrexia
Clinical narrative: Sick x8 days with headache. Received required booster (I am an RN at a Medical Center) on 2/28/22 per recommendation for health care workers. I had 3 days of body aches, low grade temperature, and 8 days of severe headaches. This required 3 days of sick calls.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Herpes zoster, Tinnitus
Clinical narrative: 2 weeks after receiving the Moderna Covid-19 vaccine on 11-29-2021, I developed shingles (I was already vaccinated with Shingrex and also immediately started treatment with Valtrex). As a result the case was mild. However, simultaneously I developed moderate to severe tinnitus (in both ears) that has not resolved and has intensified with time. I am a physician by training and understand that these are unexpected adverse events. I am unsure of causality, however, it is odd that these AEs occurred after 2 weeks of the 3rd vaccine (booster). Vaccinations are very important and I recommend vaccinating to all patients, family and friends regardless of these potentially related AEs.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Body aches for 2 weeks.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Atrial flutter, COVID-19, Cardiac failure
Clinical narrative: **PLEASE NOTE VACCINE SITE INFORMATION IS NOT AVAILABLE IN THE EHR**  Patient presented in acute on chronic respiratory failure and found to be COVID+. MICU was consulted for admission 1/18, as the patient required BiPAP and levophed gtt for hypotension. He was placed on dexamethasone, vancomycin, and zosyn upon admission. Ultimately, he was weaned from BiPAP and placed on HFNC, but his O2 requirements continued to increase. He ultimately required intubation on 1/19. Healso had persistent atrial flutter with RVR, ultimately requiring electrical cardioversion on 1/20. Given this, cardiology was consulted and he was placed on a heparin drip. Per cardiology, he was started on dronedarone as HFrEF thought due to tachyarrhythmia with thought rate control would resolve systolic function, as well as metoprolol. He required esmolol drip initiation and was then taken off dronedarone due to systolic failure. He was in periodic episodes of shock, ultimately found to have septic shock 2/2 pseudomonas UTI and pneumonia requiring cefepime. Multiple goals of care discussions were had with NOK and grandson, with ultimate decision to withdraw care due to inability to wean ventilator, continued decompensation and patient's wishes not to live on life support. Hospice was consulted with plan for discharge to hospice, however, grandson chose to withdraw care prior to transfer to hospice with patient peacefully passing at 1601 on 2/1/22.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardioversion, Death, Endotracheal intubation, General physical health deterioration, Hypotension
Clinical narrative: **PLEASE NOTE VACCINE SITE INFORMATION IS NOT AVAILABLE IN THE EHR**  Patient presented in acute on chronic respiratory failure and found to be COVID+. MICU was consulted for admission 1/18, as the patient required BiPAP and levophed gtt for hypotension. He was placed on dexamethasone, vancomycin, and zosyn upon admission. Ultimately, he was weaned from BiPAP and placed on HFNC, but his O2 requirements continued to increase. He ultimately required intubation on 1/19. Healso had persistent atrial flutter with RVR, ultimately requiring electrical cardioversion on 1/20. Given this, cardiology was consulted and he was placed on a heparin drip. Per cardiology, he was started on dronedarone as HFrEF thought due to tachyarrhythmia with thought rate control would resolve systolic function, as well as metoprolol. He required esmolol drip initiation and was then taken off dronedarone due to systolic failure. He was in periodic episodes of shock, ultimately found to have septic shock 2/2 pseudomonas UTI and pneumonia requiring cefepime. Multiple goals of care discussions were had with NOK and grandson, with ultimate decision to withdraw care due to inability to wean ventilator, continued decompensation and patient's wishes not to live on life support. Hospice was consulted with plan for discharge to hospice, however, grandson chose to withdraw care prior to transfer to hospice with patient peacefully passing at 1601 on 2/1/22.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Left ventricular failure, Mechanical ventilation, Pneumonia, Positive airway pressure therapy
Clinical narrative: **PLEASE NOTE VACCINE SITE INFORMATION IS NOT AVAILABLE IN THE EHR**  Patient presented in acute on chronic respiratory failure and found to be COVID+. MICU was consulted for admission 1/18, as the patient required BiPAP and levophed gtt for hypotension. He was placed on dexamethasone, vancomycin, and zosyn upon admission. Ultimately, he was weaned from BiPAP and placed on HFNC, but his O2 requirements continued to increase. He ultimately required intubation on 1/19. Healso had persistent atrial flutter with RVR, ultimately requiring electrical cardioversion on 1/20. Given this, cardiology was consulted and he was placed on a heparin drip. Per cardiology, he was started on dronedarone as HFrEF thought due to tachyarrhythmia with thought rate control would resolve systolic function, as well as metoprolol. He required esmolol drip initiation and was then taken off dronedarone due to systolic failure. He was in periodic episodes of shock, ultimately found to have septic shock 2/2 pseudomonas UTI and pneumonia requiring cefepime. Multiple goals of care discussions were had with NOK and grandson, with ultimate decision to withdraw care due to inability to wean ventilator, continued decompensation and patient's wishes not to live on life support. Hospice was consulted with plan for discharge to hospice, however, grandson chose to withdraw care prior to transfer to hospice with patient peacefully passing at 1601 on 2/1/22.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock, Shock, Tachyarrhythmia, Urinary tract infection pseudomonal
Clinical narrative: **PLEASE NOTE VACCINE SITE INFORMATION IS NOT AVAILABLE IN THE EHR**  Patient presented in acute on chronic respiratory failure and found to be COVID+. MICU was consulted for admission 1/18, as the patient required BiPAP and levophed gtt for hypotension. He was placed on dexamethasone, vancomycin, and zosyn upon admission. Ultimately, he was weaned from BiPAP and placed on HFNC, but his O2 requirements continued to increase. He ultimately required intubation on 1/19. Healso had persistent atrial flutter with RVR, ultimately requiring electrical cardioversion on 1/20. Given this, cardiology was consulted and he was placed on a heparin drip. Per cardiology, he was started on dronedarone as HFrEF thought due to tachyarrhythmia with thought rate control would resolve systolic function, as well as metoprolol. He required esmolol drip initiation and was then taken off dronedarone due to systolic failure. He was in periodic episodes of shock, ultimately found to have septic shock 2/2 pseudomonas UTI and pneumonia requiring cefepime. Multiple goals of care discussions were had with NOK and grandson, with ultimate decision to withdraw care due to inability to wean ventilator, continued decompensation and patient's wishes not to live on life support. Hospice was consulted with plan for discharge to hospice, however, grandson chose to withdraw care prior to transfer to hospice with patient peacefully passing at 1601 on 2/1/22.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Knee arthroplasty, Osteoarthritis
Clinical narrative: Osteoarthritis of the left knee. OPERATIVE PROCEDURE: Left total knee arthroplasty. Hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asymptomatic COVID-19, Colitis, Colonoscopy normal, Computerised tomogram abdomen abnormal
Clinical narrative: This 46 year old woman was admitted with abdominal pain. CT abdomen showed inflammatory changes in sigmoid area.  Pelvic u/s showed mild fluid in pelvis but did not show significant pathology. Last colonoscopy did not show diverticula. She was seen by surgery and GI and has improved with iv antibiotics. She is eating well and will go home to complete antibiotics. She will follow up with pcp and GI. She was diagnosed with COVID 19 on admission but required no treatment and remained asymptomatic throughout admission.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pelvic fluid collection, Ultrasound pelvis abnormal
Clinical narrative: This 46 year old woman was admitted with abdominal pain. CT abdomen showed inflammatory changes in sigmoid area.  Pelvic u/s showed mild fluid in pelvis but did not show significant pathology. Last colonoscopy did not show diverticula. She was seen by surgery and GI and has improved with iv antibiotics. She is eating well and will go home to complete antibiotics. She will follow up with pcp and GI. She was diagnosed with COVID 19 on admission but required no treatment and remained asymptomatic throughout admission.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 resulting in inpatient hospitalization" of a vaccinated patient.
Age: 81.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Brain stem haemorrhage, Cerebrovascular accident, Hemiparesis
Clinical narrative: Left pontine stroke with right hemiparesis. Treated and discharged. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 resulting in inpatient hospitalization" of a vaccinated patient.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster given 6 days early.  No computerized information available for previous vaccines. Recipient self-reported her previous vaccine was received on 08/19/2021. She presented to our clinic requesting a Moderna booster. She would be eligible to receive this on January 19th, 2021.  She presented to our clinic requesting a booster on January 11, 2021 and was denied the vaccine then because she was too early. She returned on January 13, 2021 and a booster was administered.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cardiac failure congestive, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: SOB - DX with CHF and positive COVID
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Anti-VGCC antibody positive, Areflexia, Asthenia, Balance disorder, Blood test
Clinical narrative: The pharmacist gave me the injection low on my L arm. The next week I started to have pain in my thighs, leg weakness. I had trouble stepping off a curb, and would tire on my 30 min walk, which was usual for me at that time, I was very healthy, working full time. My legs weakness and fatique continued and I thought it was related to my lack of exercise, I tried to walk more and got worse and worse. I had an annual check up appointment with my doctor 10.11.2020. I told him my legs were weak, he said to watch and wait. I continued to have symptoms and got progressively worse. I fell on 11/18/20, had a head injury & went to ER.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Cognitive disorder, Deafness, Diplopia, Disability, Dysphagia
Clinical narrative: The pharmacist gave me the injection low on my L arm. The next week I started to have pain in my thighs, leg weakness. I had trouble stepping off a curb, and would tire on my 30 min walk, which was usual for me at that time, I was very healthy, working full time. My legs weakness and fatique continued and I thought it was related to my lack of exercise, I tried to walk more and got worse and worse. I had an annual check up appointment with my doctor 10.11.2020. I told him my legs were weak, he said to watch and wait. I continued to have symptoms and got progressively worse. I fell on 11/18/20, had a head injury & went to ER.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Electromyogram abnormal, Exercise lack of, Eyelid ptosis, Fall, Fatigue
Clinical narrative: The pharmacist gave me the injection low on my L arm. The next week I started to have pain in my thighs, leg weakness. I had trouble stepping off a curb, and would tire on my 30 min walk, which was usual for me at that time, I was very healthy, working full time. My legs weakness and fatique continued and I thought it was related to my lack of exercise, I tried to walk more and got worse and worse. I had an annual check up appointment with my doctor 10.11.2020. I told him my legs were weak, he said to watch and wait. I continued to have symptoms and got progressively worse. I fell on 11/18/20, had a head injury & went to ER.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Gait disturbance, Gastrointestinal disorder, Gastrointestinal hypomotility, General physical health deterioration, Head injury
Clinical narrative: The pharmacist gave me the injection low on my L arm. The next week I started to have pain in my thighs, leg weakness. I had trouble stepping off a curb, and would tire on my 30 min walk, which was usual for me at that time, I was very healthy, working full time. My legs weakness and fatique continued and I thought it was related to my lack of exercise, I tried to walk more and got worse and worse. I had an annual check up appointment with my doctor 10.11.2020. I told him my legs were weak, he said to watch and wait. I continued to have symptoms and got progressively worse. I fell on 11/18/20, had a head injury & went to ER.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Headache, Imaging procedure, Immunoglobulin therapy, Impaired driving ability, Impaired quality of life
Clinical narrative: The pharmacist gave me the injection low on my L arm. The next week I started to have pain in my thighs, leg weakness. I had trouble stepping off a curb, and would tire on my 30 min walk, which was usual for me at that time, I was very healthy, working full time. My legs weakness and fatique continued and I thought it was related to my lack of exercise, I tried to walk more and got worse and worse. I had an annual check up appointment with my doctor 10.11.2020. I told him my legs were weak, he said to watch and wait. I continued to have symptoms and got progressively worse. I fell on 11/18/20, had a head injury & went to ER.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Impaired work ability, Investigation, Loss of personal independence in daily activities, Malaise, Mobility decreased
Clinical narrative: The pharmacist gave me the injection low on my L arm. The next week I started to have pain in my thighs, leg weakness. I had trouble stepping off a curb, and would tire on my 30 min walk, which was usual for me at that time, I was very healthy, working full time. My legs weakness and fatique continued and I thought it was related to my lack of exercise, I tried to walk more and got worse and worse. I had an annual check up appointment with my doctor 10.11.2020. I told him my legs were weak, he said to watch and wait. I continued to have symptoms and got progressively worse. I fell on 11/18/20, had a head injury & went to ER.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Muscular weakness, Myasthenic syndrome, Nervous system disorder, Pain in extremity, Product administered at inappropriate site
Clinical narrative: The pharmacist gave me the injection low on my L arm. The next week I started to have pain in my thighs, leg weakness. I had trouble stepping off a curb, and would tire on my 30 min walk, which was usual for me at that time, I was very healthy, working full time. My legs weakness and fatique continued and I thought it was related to my lack of exercise, I tried to walk more and got worse and worse. I had an annual check up appointment with my doctor 10.11.2020. I told him my legs were weak, he said to watch and wait. I continued to have symptoms and got progressively worse. I fell on 11/18/20, had a head injury & went to ER.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Reading disorder, Visual impairment
Clinical narrative: The pharmacist gave me the injection low on my L arm. The next week I started to have pain in my thighs, leg weakness. I had trouble stepping off a curb, and would tire on my 30 min walk, which was usual for me at that time, I was very healthy, working full time. My legs weakness and fatique continued and I thought it was related to my lack of exercise, I tried to walk more and got worse and worse. I had an annual check up appointment with my doctor 10.11.2020. I told him my legs were weak, he said to watch and wait. I continued to have symptoms and got progressively worse. I fell on 11/18/20, had a head injury & went to ER.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase increased, Blood creatinine normal, Blood magnesium increased, Blood potassium normal, Blood urea normal
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bundle branch block right, C-reactive protein increased, Chest pain, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Haematocrit decreased, Haemoglobin decreased, Hyperuricaemia, Hypokalaemia
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Left ventricular hypertrophy, Leukopenia, Musculoskeletal chest pain, Painful respiration, Pericarditis
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary arterial pressure abnormal, Troponin normal, White blood cell count decreased
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time shortened, Anticoagulant therapy, Benzodiazepine drug level, Blood cholesterol normal, Blood creatine phosphokinase increased
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine normal, Blood magnesium normal, Blood potassium decreased, Blood thyroid stimulating hormone normal, Blood triglycerides normal
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood urea normal, Blood uric acid normal, Bordetella test negative, Brain natriuretic peptide normal, Bundle branch block right
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Chest X-ray normal, Chest pain, Chlamydia test negative, Coronavirus test negative
Clinical narrative: Pt given Moderna Vaccination on 09 Feb 2022.  No immediate reactions noted.  On 28FEB2022 SM began to experience chest wall pain with inspiration made worse with laying down.  Pain continued throuout the day and at 2200 went to Emergency Dept for evaluation.  Pts admitting diagnosis was Chest pain, Pericarditis,  Hypokalemia, Hyperuremia, Leukopenia, elevated CRP.  Pt was admitted for Cardiology consult.   Pt was inpatient from 28Feb 22 until 03Mar22.  Pt was discharged on Colchicine 0.6mg bid, ASA 81mg daily, famotidine 20mg bid, allopurinol 100mg bid.  Pt will be on these meds for 2 months.  Pt advised not to receive the second dose of Moderna vaccination.